Literature DB >> 19890058

P-selectin glycoprotein ligand-1 negatively regulates T-cell immune responses.

Masanori Matsumoto1, Masayuki Miyasaka, Takako Hirata.   

Abstract

Cell surface sialomucins often act as antiadhesive molecules by virtue of their extended structure and negative charge. CD43 is one such sialomucin, expressed on most leukocytes. P-selectin glycoprotein ligand-1 (PSGL-1) is another sialomucin expressed by leukocytes. It serves as a major selectin ligand, but no antiadhesive role for it has been described. In this study, we showed that PSGL-1-deficient T cells, like CD43-deficient T cells, exhibited increased adhesion and proliferation compared with wild-type cells. The loss of both PSGL-1 and CD43 led to a further increase in T cell adhesion and proliferation. The reexpression of full-length PSGL-1 or CD43 in double-deficient CD4(+) T cells reversed their increased adhesion and proliferation phenotype. Using chimeric constructs of human CD8 and either PSGL-1 or CD43, we demonstrated that the intracellular domain of PSGL-1 or CD43 is required for suppressing proliferation but not adhesion. Furthermore, in a mouse model of inflammatory bowel disease induced by the adoptive transfer of naive T cells into RAG-deficient hosts, a PSGL-1 deficiency exacerbated the development of inflammation. These results reveal a novel regulatory role for PSGL-1 in T cell adhesion and proliferation and suggest that PSGL-1 negatively regulates T cell immune responses in vivo.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19890058     DOI: 10.4049/jimmunol.0902173

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  16 in total

Review 1.  PSGL-1: A New Player in the Immune Checkpoint Landscape.

Authors:  Roberto Tinoco; Dennis C Otero; Amy A Takahashi; Linda M Bradley
Journal:  Trends Immunol       Date:  2017-03-02       Impact factor: 16.687

2.  Virion-incorporated PSGL-1 and CD43 inhibit both cell-free infection and transinfection of HIV-1 by preventing virus-cell binding.

Authors:  Tomoyuki Murakami; Nancy Carmona; Akira Ono
Journal:  Proc Natl Acad Sci U S A       Date:  2020-03-19       Impact factor: 11.205

Review 3.  HIV-1 entry: Duels between Env and host antiviral transmembrane proteins on the surface of virus particles.

Authors:  Tomoyuki Murakami; Akira Ono
Journal:  Curr Opin Virol       Date:  2021-08-12       Impact factor: 7.121

4.  Targeting the PSGL-1 Immune Checkpoint Promotes Immunity to PD-1-Resistant Melanoma.

Authors:  Karla M Viramontes; Emily N Neubert; Julia M DeRogatis; Monique L Henriquez; Christian F Guerrero-Juarez; Roberto Tinoco
Journal:  Cancer Immunol Res       Date:  2022-05-03       Impact factor: 12.020

5.  PD-1 Immune Checkpoint Blockade and PSGL-1 Inhibition Synergize to Reinvigorate Exhausted T Cells.

Authors:  Karla M Viramontes; Emily N Neubert; Julia M DeRogatis; Roberto Tinoco
Journal:  Front Immunol       Date:  2022-06-14       Impact factor: 8.786

6.  VISTA is an acidic pH-selective ligand for PSGL-1.

Authors:  Linhui Julie Su; Jason Pinckney; David Critton; Robert J Johnston; Eric Boyer; Arathi Krishnakumar; Martin Corbett; Andrew L Rankin; Rose Dibella; Lynne Campbell; Gaelle H Martin; Hadia Lemar; Thomas Cayton; Richard Y-C Huang; Xiaodi Deng; Akbar Nayeem; Haibin Chen; Burce Ergel; Joseph M Rizzo; Aaron P Yamniuk; Sanjib Dutta; Justine Ngo; Andrea Olga Shorts; Radha Ramakrishnan; Alexander Kozhich; Jim Holloway; Hua Fang; Ying-Kai Wang; Zheng Yang; Kader Thiam; Ginger Rakestraw; Arvind Rajpal; Paul Sheppard; Michael Quigley; Keith S Bahjat; Alan J Korman
Journal:  Nature       Date:  2019-10-23       Impact factor: 49.962

7.  Regulatory T cells suppress the late phase of the immune response in lymph nodes through P-selectin glycoprotein ligand-1.

Authors:  Stefano Angiari; Barbara Rossi; Laura Piccio; Bernd H Zinselmeyer; Simona Budui; Elena Zenaro; Vittorina Della Bianca; Simone D Bach; Elio Scarpini; Matteo Bolomini-Vittori; Gennj Piacentino; Silvia Dusi; Carlo Laudanna; Anne H Cross; Mark J Miller; Gabriela Constantin
Journal:  J Immunol       Date:  2013-10-30       Impact factor: 5.422

Review 8.  Advances in the Immunomodulatory Properties of Glycoantigens in Cancer.

Authors:  Valeria da Costa; Teresa Freire
Journal:  Cancers (Basel)       Date:  2022-04-07       Impact factor: 6.575

9.  PSGL-1 Is an Immune Checkpoint Regulator that Promotes T Cell Exhaustion.

Authors:  Roberto Tinoco; Florent Carrette; Monique L Barraza; Dennis C Otero; Jonathan Magaña; Marcus W Bosenberg; Susan L Swain; Linda M Bradley
Journal:  Immunity       Date:  2016-05-17       Impact factor: 31.745

10.  PSGL-1 on Leukocytes is a Critical Component of the Host Immune Response against Invasive Pneumococcal Disease.

Authors:  Elisa Ramos-Sevillano; Ana Urzainqui; Belén de Andrés; Rafael González-Tajuelo; Mirian Domenech; Fernando González-Camacho; Francisco Sánchez-Madrid; Jeremy S Brown; Ernesto García; Jose Yuste
Journal:  PLoS Pathog       Date:  2016-03-14       Impact factor: 6.823

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.